InsiderTrades

Form 4 for HALO HALOZYME THERAPEUTICS, INC.

Accepted 2024-02-20 00:00:00 ET · period of report 2024-02-16 · accession 0001415889-24-004475 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-02-20 2024-02-16 HALO LaBrosse Nicole SVP, CFO M - OptEx $0.00 +10.4K 18.3K +132% $0
DM 2024-02-20 2024-02-16 HALO LaBrosse Nicole SVP, CFO F - Tax $36.10 -5,601 15.5K -27% -$202.2K
DM 2024-02-20 2024-02-16 HALO LaBrosse Nicole SVP, CFO M - OptEx $0.00 -10.4K 10.2K -51% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-02-16 M A 5,093 $0.00 15,752 D — —
2 Common Common Stock 2024-02-16 F D 2,737 $36.10 13,015 D — — (F1) The reported disposition of 2,737 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
3 Common Common Stock 2024-02-16 M A 5,329 $0.00 18,344 D — —
4 Common Common Stock 2024-02-16 F D 2,864 $36.10 15,480 D — — (F2) The reported disposition of 2,864 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
5 Derivative Restricted Stock Units 2024-02-16 M D 5,329 $0.00 15,987 D $0.00 · — to — 5,329 Common Stock (F3) This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.
6 Derivative Restricted Stock Units 2024-02-16 M D 5,093 $0.00 10,186 D $0.00 · — to — 5,093 Common Stock (F3) This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.